Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’

• Pauline Versteegen,
• Marta Valente Pinto,
• Alex M. Barkoff,
• Pieter G.M. van Gageldonk,
• Jan van de Kassteele,
• Marlies A. van Houten,
• Elisabeth A.M. Sanders,
• Ronald de Groot,
• Dimitri A. Diavatopoulos,
• Sagida Bibi,
• Raakel Luoto,
• Qiushui He,
• Anne-Marie Buisman,
• Dominic F. Kelly,
• Jussi Mertsola,
• Guy A.M. Berbers

Affiliations

Pauline Versteegen

National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Antonie van Leeuwenhoeklaan 9, Bilthoven 3720 BA, the Netherlands

Marta Valente Pinto

University of Oxford, Department of Paediatrics, Oxford Vaccine Group, Oxford OX3 7LE, United Kingdom

Alex M. Barkoff

University of Turku, Institute of Biomedicine, Microbiology, Virology and Immunology, and Turku University Hospital, Turku 20500, Finland

Pieter G.M. van Gageldonk

National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Antonie van Leeuwenhoeklaan 9, Bilthoven 3720 BA, the Netherlands

Jan van de Kassteele

National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Antonie van Leeuwenhoeklaan 9, Bilthoven 3720 BA, the Netherlands

Marlies A. van Houten

Spaarne Gasthuis, Spaarne Gasthuis Academy, Hoofddorp 2134 TM, the Netherlands

Elisabeth A.M. Sanders

National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Antonie van Leeuwenhoeklaan 9, Bilthoven 3720 BA, the Netherlands; University of Turku, Institute of Biomedicine, Microbiology, Virology and Immunology, and Turku University Hospital, Turku 20500, Finland

Ronald de Groot

Radboud University Medical Centre, Radboud Institute for Molecular Life Sciences, Department of Laboratory Medicine, Nijmegen 6525 GA, the Netherlands

Dimitri A. Diavatopoulos

Radboud University Medical Centre, Radboud Institute for Molecular Life Sciences, Department of Laboratory Medicine, Nijmegen 6525 GA, the Netherlands

Sagida Bibi

University of Oxford, Department of Paediatrics, Oxford Vaccine Group, Oxford OX3 7LE, United Kingdom

Raakel Luoto

University of Turku, Institute of Biomedicine, Microbiology, Virology and Immunology, and Turku University Hospital, Turku 20500, Finland

Qiushui He

University of Turku, Institute of Biomedicine, Microbiology, Virology and Immunology, and Turku University Hospital, Turku 20500, Finland

Anne-Marie Buisman

National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Antonie van Leeuwenhoeklaan 9, Bilthoven 3720 BA, the Netherlands

Dominic F. Kelly

Wilhelmina Children's Hospital, Department of Paediatric Immunology and Infectious Diseases, Lundlaan 6, 3584 EA Utrecht, the Netherlands; Oxford University Hospitals NHS Foundation Trust, Headington, Oxford OX3 9DU, United Kingdom

Jussi Mertsola

University of Turku, Institute of Biomedicine, Microbiology, Virology and Immunology, and Turku University Hospital, Turku 20500, Finland

Guy A.M. Berbers

National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Antonie van Leeuwenhoeklaan 9, Bilthoven 3720 BA, the Netherlands; Corresponding author.